SectorBiological Technology
Established Date05/02/2016
Listing Date25/09/2020
ExchangeNASDAQ Stock Exchange
Full-time Employees79
Fiscal Year Ends31/12
Security TypeCommon stock
Office address175 Innovation Boulevard, Wilmington, Delaware 19805
Business
IntroductionPrelude Therapeutics Incorporated, founded in Delaware on February 5, 2016, is a clinical-stage precision oncology company dedicated to discovering and developing small molecule therapies optimized for key driving mechanisms of highly unmet cancer needs.
